127 related articles for article (PubMed ID: 15473668)
1. Site-specific 99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain.
Jeong JM; Lee J; Paik CH; Kim DK; Lee DS; Chung JK; Lee MC
Arch Pharm Res; 2004 Sep; 27(9):961-7. PubMed ID: 15473668
[TBL] [Abstract][Full Text] [Related]
2. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
Baidoo KE; Scheffel U; Lever SZ
Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
[TBL] [Abstract][Full Text] [Related]
3. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method.
Pak KY; Nedelman MA; Tam SH; Wilson E; Daddona PE
Int J Rad Appl Instrum B; 1992 Aug; 19(6):669-77. PubMed ID: 1522021
[TBL] [Abstract][Full Text] [Related]
4. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
5. Advances in 99mTc-labeling of antibodies.
Fritzberg AR
Nuklearmedizin; 1987 Feb; 26(1):7-12. PubMed ID: 3588319
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
[TBL] [Abstract][Full Text] [Related]
7. Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.
Hnatowich DJ; Mardirossian G; Rusckowski M; Fogarasi M; Virzi F; Winnard P
J Nucl Med; 1993 Jan; 34(1):109-19. PubMed ID: 8418250
[TBL] [Abstract][Full Text] [Related]
8. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
[TBL] [Abstract][Full Text] [Related]
10. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
[TBL] [Abstract][Full Text] [Related]
11. Direct labeling of proteins with 99mTc.
Rhodes BA
Int J Rad Appl Instrum B; 1991; 18(7):667-76. PubMed ID: 1787075
[TBL] [Abstract][Full Text] [Related]
12. Studies on the uptake mechanisms of 99mTc-labeled antibodies by liver tissue.
Xue LY; Noujaim AA; Sykes TR; Peng Z
Q J Nucl Med; 1996 Jun; 40(2):176-81. PubMed ID: 8909103
[TBL] [Abstract][Full Text] [Related]
13. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
Pietersz GA; Patrick MR; Chester KA
J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
[TBL] [Abstract][Full Text] [Related]
15. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
17. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.
Childs RL; Hnatowich DJ
J Nucl Med; 1985 Mar; 26(3):293-9. PubMed ID: 3882905
[TBL] [Abstract][Full Text] [Related]
18. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
Garron JY; Moinereau M; Pasqualini R; Saccavini JC
Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3.
Morales AA; Crespo FZ; Gandolff GN; Iznaga Escobar N; Pérez NP; Hernández JC
Nucl Med Biol; 1998 Jan; 25(1):25-30. PubMed ID: 9466358
[TBL] [Abstract][Full Text] [Related]
20. Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Govindan SV; Goldenberg DM; Griffiths GL; Leung SO; Losman MJ; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5721s-5725s. PubMed ID: 7493334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]